Publications by authors named "Patrick Grohs"

Claim this Profile
I
Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated bacteremia treated with 14 days of antibiotics: a retrospective cohort study.
Damien Blez, Luc Labarbe, Patrick Grohs, Jean-Luc Mainardi, Jean-Philippe Barnier

Microbiol Spectr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study.
Matthieu Holub, David Lebeaux, Patrick Grohs, Laure Joseph, Olivier Pellerin

Eur J Clin Microbiol Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the New VITEK MS PRIME System with the Matrix-Assisted Laser Desorption Ionization Biotyper Microflex LT for the Identification of Microorganisms.
Patrick Grohs, Elodie Remaud, Cybill Lath, Kim Vuong, Marie-Lize Parolini

Ann Lab Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors of toxigenic asymptomatic carriage in 11 French hospitals.
Sarah Jolivet, Jeanne Couturier, Patrick Grohs, Aurélie Vilfaillot, Jean-Ralph Zahar

Front Med (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
Patrick Grohs, Aurélie Vilfaillot, Jean Ralph Zahar, Frédéric Barbut, Pierre Frange

J Antimicrob Chemother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriateness of empirical antibiotic prescription for bloodstream infections in an emergency department from 2006 to 2018: impact of the spread of ESBL-producing Enterobacterales.
Marie Clemenceau, Samira Ahmed-Elie, Aurelie Vilfaillot, Richard Chocron, Fabrice Compain, Patrick Grohs

Eur J Clin Microbiol Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of version 2.5 of QMAC-dRAST for rapid antimicrobial susceptibility testing with reduced sample-to-answer turnaround time and an integrated expert system.
Patrick Grohs, Simon Picard, Jean-Luc Mainardi, Isabelle Podglajen

Infect Dis Now· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates.
Patrick Grohs, Emilie Rondinaud, Myriam Fourar, Karama Rouis, Jean-Luc Mainardi

J Microbiol Methods· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
Vincent Mathy, Patrick Grohs, Fabrice Compain

J Med Microbiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis.
Patrick Grohs, Gary Taieb, Philippe Morand, Iheb Kaibi, Isabelle Podglajen

Antimicrob Agents Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for different levels of tet(M) expression in Streptococcus pneumoniae clinical isolates.
Patrick Grohs, Patrick Trieu-Cuot, Isabelle Podglajen, Sophie Grondin, Arnaud Firon

Antimicrob Agents Chemother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robustness of two MALDI-TOF mass spectrometry systems for bacterial identification.
Etienne Carbonnelle, Patrick Grohs, Hervé Jacquier, Nesrine Day, Sylvie Tenza

J Microbiol Methods· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of MIC determination for Streptococcus pneumoniae using the Sirscan2000automatic MIC determination system.
Patrick Grohs, Claire Janoir, Sophie Grondin, Sylvie Simon, Gaëlle Bonnet

Diagn Microbiol Infect Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria.
Guillaume Kac, Patrick Grohs, Pierre Durieux, Ludovic Trinquart, Mathilde Gueneret

Arch Intern Med· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of routine use of the anaerobic blood culture bottle.
Patrick Grohs, Jean-Luc Mainardi, Isabelle Podglajen, Xavier Hanras, C Eckert

J Clin Microbiol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.
Patrick Grohs, Isabelle Podglajen, Laurent Gutmann

Antimicrob Agents Chemother· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.
Patrick Grohs, Serge Houssaye, Agnès Aubert, Laurent Gutmann, Emmanuelle Varon

Antimicrob Agents Chemother· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Patrick Grohs, Marie-Dominique Kitzis, Laurent Gutmann

Antimicrob Agents Chemother· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis